Chimeric rabies viruses for trans-species comparison of lyssavirus glycoprotein ectodomain functions in virus replication and pathogenesis

Berliner und Munchener Tierarztliche Wochenschrift

Volumn 125, Issue 5-6, 2012, Pages 219-227

  Genz, Berit ^c   Nolden, Tobias ^a   Negatsch, Alexandra ^a   Teifke, Jens Peter ^a   Conzelmann, Karl Klaus ^b   Finke, Stefan ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Glycoprotein; Lyssavirus pathogenicity; Rabies virus

Indexed keywords

GLYCOPROTEIN; HYBRID PROTEIN; NUCLEOPROTEIN; VIRUS ANTIGEN; VIRUS PROTEIN;

ANIMAL; ARTICLE; BRAIN CORTEX; CELL CULTURE; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; METABOLISM; MORTALITY; MOUSE; NERVE CELL; PATHOGENICITY; RABIES VIRUS; RAT; RHABDOVIRUS INFECTION; SPRAGUE DAWLEY RAT; VIROLOGY; VIRUS REPLICATION;

ANIMALS; ANTIGENS, VIRAL; CELL LINE; CELLS, CULTURED; CEREBRAL CORTEX; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LYSSAVIRUS; MICE; NEURONS; NUCLEOPROTEINS; RABIES VIRUS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; RHABDOVIRIDAE INFECTIONS; VIRAL PROTEINS; VIRUS REPLICATION;

LYSSAVIRUS; MUS; RABIES VIRUS;

EID: 84866158440     PISSN: 00059366     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Brookes SM, Klopfleisch R, Müller T, Healy DM, Teifke JP, Lange E, Kliemt J, Johnson N, Johnson L, Kaden V, Vos A, Fooks AR (2007): Susceptibility of sheep to European bat lyssavirus type-1 and -2 infection: a clinical pathogenesis study. Vet Microbiol 125: 210-223.
2. Brzözka K, Finke S, Conzelmann KK (2005): Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J Virol 79: 7673-7681.
3. Brzözka K, Finke S, Conzelmann KK (2006): Inhibition of interferon signaling by rabies virus phosphoprotein P: activation-dependent binding of STAT1 and STAT2. J Virol 80: 2675-2683.
4. Buchholz UJ, Finke S, Conzelmann KK (1999): Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73,251-259.
5. Chelbi-Alix MK, Vidy A, El BJ, Blondel D (2006): Rabies viral mechanisms to escape the IFN system: The viral protein P interferes with IRF-3, Statl, and PML nuclear bodies. J Interferon Cytokine Res 26: 271-280.
6. Cliquet F, Picard-Meyer E (2004): Rabies and rabies-related viruses: a modern perspective on an ancient disease. Rev Sei Tech 23: 625-642.
7. Cox JH, Dietzschold B, Schneider LG (1977): Rabies virus glycoprotein. II. Biological and serological characterization. Infect Immun 16: 754-759.
8. Dietzgen RG, Calisher CH, Kurath G, Kuzmin IV, Rodriguez LL, Stone DM, et al. (2012): Family Rhabdoviridae. In: King AM, Adams MJ, Carstens EB, Lefkowitz EJ (eds.). Virus taxonomy: classifi cation and nomenclature of viruses. Ninth Report of the International Committee on Taxonomy of Viruses. San Diego: Elsevier.
9. Faber M, Pulmanausahakul R, Hodawadekar SS, Spitsin S, McGettigan JP, Schnell MJ, Dietzschold B (2002): Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response. J Virol 76: 3374-3381.
10. Faber M, Pulmanausahakul R, Nagao K, Prosniak M, Rice AB, Koprowski H, Schnell MJ, Dietzschold B (2004): Identification of viral genomic elements responsible for rabies virus neuroinvasiveness. Proc Natl Acad Sei U S A 101: 16328-16332.
11. Finke S, Conzelmann KK (1999): Virus promoters determine interference by defective RNAs: selective amplification of mini-RNA vectors and rescue from cDNA by a 3' copy-back ambi-sense rabies virus. J Virol 73: 3818-3825.
12. Finke S, Conzelmann KK (2003): Dissociation of rabies virus matrix protein functions in regulation of viral RNA synthesis and virus assembly. J Virol 77: 12074-12082.
13. Mueller-Waldeck R, Conzelmann, KK (2003): Rabies virus matrix protein regulates the balance of virus transcription and replication. J Gen Virol. 84: 1613-1621.
14. Finke S, Conzelmann KK (2005): Replication strategies of rabies virus. Virus Res 111: 120-131.
15. Finke S, Granzow H, Hurst J, Pollin R, Mettenleiter TC (2010): Intergenotypic replacement of lyssavirus matrix proteins demonstrates the role of lyssavirus M proteins in intracellular virus accumulation. J Virol 84: 1816-1827.
16. Foley HD, McGettigan JP, Siler CA, Dietzschold B, Schnell MJ (2000): A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection. Proc Natl Acad Sei U S A 97: 14680-14685.
17. Fooks AR, McElhinney LM, Pounder DJ, Finnegan CJ, Mansfield K, Johnson N, Brookes SM, Parsons G, White K, Mclntyre PG, Nathwani D (2003): Case report: isolation of a European bat lyssavirus type 2a from a fatal human case of rabies encephalitis. J Med Virol 71: 281-289.
18. Freuling CM, Beer M, Conraths FJ, Finke S, Hoffmann B, Keller B, Kliemt J, Mettenleiter TC, Muhlbach E, Teifke JP, Wohlsein P, Muller, T (2011): Novel Lyssavirus in Natterer's Bat, Germany. Emerging infectious diseases 17: 1519-1522.
19. Gaudin Y, Ruigrok, RW, Tuffereau C, Knossow M, Flamand A (1992): Rabies virus glycoprotein is a trimer. Virology 187: 627-632.
20. Gholami A, Kassis R, Real E, Delmas O, Guadagnini S, Larrous F, Obach D, Prevost MC, Jacob Y, Bourhy H (2008): Mitochondrial dysfunction in lyssavirus-induced apoptosis. J Virol 82: 4774-4784.
21. Ito N, Takayama M, Yamada K, Sugiyama M, Minamoto N (2001): Rescue of rabies virus from cloned cDNA and identification of the pathogenicity-related gene: glycoprotein gene is associated with virulence for adult mice. J Virol 75: 9121-9128.
22. Johnson N, Vos A, Freuling C, Tordo N, Fooks AR, Muller T (2010): Human rabies due to lyssavirus infection of bat origin. Veterinary microbiology 142: 151-159.
23. Kassis R, Larrous F, Estaquier J, Bourhy H (2004): Lyssavirus matrix protein induces apoptosis by a TRAIL-dependent mechanism involving caspase-8 activation. J Virol 78: 6543-6555.
24. Kato S, Kuramochi M, Takasumi K, Kobayashi K, Inoue KI, Takahara D, Hitoshi S, Ikenaka K, Shimada T, Takada M (2011): Neuron-Specific Gene Transfer through Retrograde Transport of Lentiviral Vector Pseudotyped with a Novel Type of Fusion Envelope Glycoprotein. Hum Gene Ther Sep 9 [Epub ahead of print].
25. Kuzmin IV, Mayer AE, Niezgoda M, Markotter W, Agwanda B, Breiman RF, Rupprecht CE (2010): Shimoni bat virus, a new representative of the Lyssavirus genus. Virus research 149: 197-210.
26. Lumio J, Hillbom M, Roine R, Ketonen L, Haltia M, Valle M, Neuvonen E, Lahdevirta, J (1986): Human rabies of bat origin in Europe. Lancet 1: 378.
27. Maillard AP, Gaudin Y (2002): Rabies virus glycoprotein can fold in two alternative, antigenically distinct conformations depending on membrane-anchor type. J Gen Virol 83: 1465-1476.
28. Maresch C, Granzow H, Negatsch A, Klupp BG, Fuchs W, Teifke JP, Mettenleiter TC (2010): Ultrastructural analysis of virion formation and anterograde intraaxonal transport of the alphaherpesvirus Pseudorabies virus in primary neurons. J Virol 84: 5528-5539.
29. Mebatsion T (2001): Extensive attenuation of rabies virus by simultaneously modifying the dynein light chain binding site in the P protein and replacing Arg333 in the G protein. J Virol 75: 11496-11502.
30. Mebatsion T, Conzelmann KK (1996): Specific infection of CD4+ target cells by recombinant rabies virus pseudotypes carrying the HIV-1 envelope spike protein. Proc Natl Acad Sei U S A 93: 11366-11370.
31. Mebatsion T, Konig M, Conzelmann KK (1996): Budding of rabies virus particles in the absence of the spike glycoprotein. Cell 84: 941-951.
32. Mebatsion T, Schnell MJ, Conzelmann KK (1995): Mokola virus glycoprotein and chimeric proteins can replace rabies virus glycoprotein in the rescue of infectious defective rabies virus particles. J Virol 69: 1444-1451.
33. Morimoto K, Foley HD, McGettigan JP, Schnell MJ, Dietzschold B (2000): Reinvestigation of the role of the rabies virus glycoprotein in viral pathogenesis using a reverse genetics approach. J Neurovirol 6: 373-381.
34. Morimoto K, Hooper DC, Spitsin S, Koprowski H, Dietzschold B (1999): Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures. JVirol 73: 510-518.
35. Müller T, Cox J, Peter W, Schafer R, Johnson N, McElhinney LM, Geue JL, Tjornehoj K, Fooks AR (2004): Spill-over of European bat lyssavirus type 1 into a stone marten (Martes foina) in Germany. J Vet Med B Infect Dis Vet Public Health 51: 49-5l.
36. Nathwani D, Mclntyre PG, White K, Shearer AJ, Reynolds N, Walker D, Orange GV, Fooks, AR (2003): Fatal human rabies caused by European bat Lyssavirus type 2a infection in Scotland. Clin Infect Dis 37: 598-601.
37. Orbanz J, Finke S (2010): Generation of recombinant European bat lyssavirus type 1 and inter-genotypic compatibility of lyssavirus genotype 1 and 5 antigenome promoters. Arch Virol 155: 1631-1641.
38. Prehaud C, Lay S, Dietzschold B, Lafon M (2003): Glycoprotein of nonpathogenic rabies viruses is a key determinant of human cell apoptosis. JVirol 77: 10537-10547.
39. Prehaud C, Wolff N, Terrien E, Lafage M, Megret F, Babault N, Cordier F, Tan GS, Maitrepierre E, Menager P, Chopy D, Hoos S, England P, Delepierre M, Schnell MJ, Buc H, Lafon M (2010): Attenuation of rabies virulence: takeover by the cytoplasmic domain of its envelope protein. Sei Signal 3: ra5.
40. Pulmanausahakul R, Li J, Schnell MJ, Dietzschold B (2008): The glycoprotein and the matrix protein of rabies virus affect pathogenicity by regulating viral replication and facilitating cell-to-cell spread. JVirol 82: 2330-2338.
41. Rieder M, Finke S, Conzelmann KK (2012): Interferon in Lyssavirus Infection. BMTW this issue.
42. Schneider LG, Barnard BJH, Schneider HP, Odegaard OA, Müller J, et al. (1985): Mechanisms of rabies virus neutralization by glycoprotein-specific monoclonal antibodies. Rabies in the Tropics. Springer, Berlin.
43. Schnell MJ, Buonocore L, Boritz E, Ghosh HP, Chernish R, Rose JK (1998): Requirement for a non-specific glycoprotein cytoplasmic domain sequence to drive efficient budding of vesicular stomatitis vims. EMBO J17: 1289-1296.
44. Schnell MJ, Buonocore L, Kretzschmar E, Johnson E, Rose JK (1996): Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Proc Natl Acad Sei U S A 93: 11359-11365.
45. Schnell MJ, Mebatsion T, Conzelmann KK (1994): Infectious rabies viruses from cloned cDNA. EMBO J13: 4195-4203.
46. Tan GS, Preuss MA, Williams JC, Schnell MJ (2007): The dynein light chain 8 binding motif of rabies virus phosphoprotein promotes efficient viral transcription. Proc Natl Acad Sei U S A 104: 7229-7234.
47. Tjornehoj K, Fooks AR, Agerholm JS, Ronsholt L (2006): Natural and experimental infection of sheep with European bat lyssavirus type-1 of Danish bat origin. J Comp Rathol 134: 190-201.
48. Vidy A, Chelbi-Alix M, Blondel D (2005): Rabies virus P protein interacts with STAT1 and inhibits interferon signal transduction pathways. JVirol 79: 14411-14420.
49. Vidy A, El BJ, Chelbi-Alix MK, Blondel D (2007): The nucleocy-toplasmic rabies virus P protein counteracts interferon signaling by inhibiting both nuclear accumulation and DNA binding of STAT1. JVirol 81: 4255-4263.
50. Wickersham IR, Lyon DC, Barnard RJ, Mori T, Finke S, Conzelmann KK, Young JA, Callaway EM (2007): Monosynaptic restriction of transsynaptic tracing from single, genetically targeted neurons. Neuron 53: 639-647.
51. Wirblich C, Schnell MJ (2011): Rabies virus (RV) glycoprotein expression levels are not critical for pathogenicity of RV. J Virol 85: 697-704.